Donate

ACRF Single Cell Proteomics Laboratory

Research institute
The University of Sydney, NSW
Amount Granted
$1.8 million
Year Granted
2025
Cancer Targeted
Blood cancer
Research Area
Cancer Proteomics

$1.8 million million awarded to The University of Sydney in New South Wales to establish the ACRF Single Cell Proteomics Laboratory (SCPL).

ACRF Single Cell Proteomics Laboratory will be Australia’s first, dedicated single-cell cancer proteomics laboratory, establishing a national platform and  enabling researchers around the country to unlock unprecedented insights into how individual cancer and immune cells behave and respond to treatment.   

Expected outcomes include improved precision medicine, so oncologists can make the best treatment choice for individual patients. It will also enable basic discoveries about cancer cell biology and help researchers understand why some immunotherapies (e.g. CAR T-cells) don’t work for all patients.

Access to this new technology in research will be like installing a brighter lamppost on a dark street—revealing entire pathways we didn’t know existed.  

The ability to analyse proteins from individual cancer cells and cancer-associated cells is incredibly unique and only through significant technology development has this capability been unlocked. Discoveries will benefit research around the world.